Cargando…

Small-Sized Co-Polymers for Targeted Delivery of Multiple Imaging and Therapeutic Agents

Research has increasingly focused on the delivery of high, often excessive amounts of drugs, neglecting negative aspects of the carrier’s physical preconditions and biocompatibility. Among them, little attention has been paid to “small but beautiful” design of vehicle and multiple cargo to achieve e...

Descripción completa

Detalles Bibliográficos
Autores principales: Ljubimova, Julia Y., Ramesh, Arshia, Israel, Liron L., Holler, Eggehard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625475/
https://www.ncbi.nlm.nih.gov/pubmed/34835760
http://dx.doi.org/10.3390/nano11112996
_version_ 1784606430485020672
author Ljubimova, Julia Y.
Ramesh, Arshia
Israel, Liron L.
Holler, Eggehard
author_facet Ljubimova, Julia Y.
Ramesh, Arshia
Israel, Liron L.
Holler, Eggehard
author_sort Ljubimova, Julia Y.
collection PubMed
description Research has increasingly focused on the delivery of high, often excessive amounts of drugs, neglecting negative aspects of the carrier’s physical preconditions and biocompatibility. Among them, little attention has been paid to “small but beautiful” design of vehicle and multiple cargo to achieve effortless targeted delivery into deep tissue. The design of small biopolymers for deep tissue targeted delivery of multiple imaging agents and therapeutics (mini-nano carriers) emphasizes linear flexible polymer platforms with a hydrodynamic diameter of 4 nm to 10 nm, geometrically favoring dynamic juxtaposition of ligands to host receptors, and economic drug content. Platforms of biodegradable, non-toxic poly(β-l-malic acid) of this size carrying multiple chemically bound, optionally nature-derived or synthetic affinity peptides and drugs for a variety of purposes are described in this review with specific examples. The size, shape, and multiple attachments to membrane sites accelerate vascular escape and fast blood clearance, as well as the increase in medical treatment and contrasts for tissue imaging. High affinity antibodies routinely considered for targeting, such as the brain through the blood–brain barrier (BBB), are replaced by moderate affinity binding peptides (vectors), which penetrate at high influxes not achievable by antibodies.
format Online
Article
Text
id pubmed-8625475
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86254752021-11-27 Small-Sized Co-Polymers for Targeted Delivery of Multiple Imaging and Therapeutic Agents Ljubimova, Julia Y. Ramesh, Arshia Israel, Liron L. Holler, Eggehard Nanomaterials (Basel) Review Research has increasingly focused on the delivery of high, often excessive amounts of drugs, neglecting negative aspects of the carrier’s physical preconditions and biocompatibility. Among them, little attention has been paid to “small but beautiful” design of vehicle and multiple cargo to achieve effortless targeted delivery into deep tissue. The design of small biopolymers for deep tissue targeted delivery of multiple imaging agents and therapeutics (mini-nano carriers) emphasizes linear flexible polymer platforms with a hydrodynamic diameter of 4 nm to 10 nm, geometrically favoring dynamic juxtaposition of ligands to host receptors, and economic drug content. Platforms of biodegradable, non-toxic poly(β-l-malic acid) of this size carrying multiple chemically bound, optionally nature-derived or synthetic affinity peptides and drugs for a variety of purposes are described in this review with specific examples. The size, shape, and multiple attachments to membrane sites accelerate vascular escape and fast blood clearance, as well as the increase in medical treatment and contrasts for tissue imaging. High affinity antibodies routinely considered for targeting, such as the brain through the blood–brain barrier (BBB), are replaced by moderate affinity binding peptides (vectors), which penetrate at high influxes not achievable by antibodies. MDPI 2021-11-08 /pmc/articles/PMC8625475/ /pubmed/34835760 http://dx.doi.org/10.3390/nano11112996 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Ljubimova, Julia Y.
Ramesh, Arshia
Israel, Liron L.
Holler, Eggehard
Small-Sized Co-Polymers for Targeted Delivery of Multiple Imaging and Therapeutic Agents
title Small-Sized Co-Polymers for Targeted Delivery of Multiple Imaging and Therapeutic Agents
title_full Small-Sized Co-Polymers for Targeted Delivery of Multiple Imaging and Therapeutic Agents
title_fullStr Small-Sized Co-Polymers for Targeted Delivery of Multiple Imaging and Therapeutic Agents
title_full_unstemmed Small-Sized Co-Polymers for Targeted Delivery of Multiple Imaging and Therapeutic Agents
title_short Small-Sized Co-Polymers for Targeted Delivery of Multiple Imaging and Therapeutic Agents
title_sort small-sized co-polymers for targeted delivery of multiple imaging and therapeutic agents
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625475/
https://www.ncbi.nlm.nih.gov/pubmed/34835760
http://dx.doi.org/10.3390/nano11112996
work_keys_str_mv AT ljubimovajuliay smallsizedcopolymersfortargeteddeliveryofmultipleimagingandtherapeuticagents
AT ramesharshia smallsizedcopolymersfortargeteddeliveryofmultipleimagingandtherapeuticagents
AT israellironl smallsizedcopolymersfortargeteddeliveryofmultipleimagingandtherapeuticagents
AT hollereggehard smallsizedcopolymersfortargeteddeliveryofmultipleimagingandtherapeuticagents